1. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-[beta] signaling. (Article)
- Author
-
Hanyu, Aki, Ishidou, Yasuhiro, Ebisawa, Takanori, Shimanuki, Tomomasa, Imamura, Takeshi, and Miyazono, Kohei
- Subjects
Growth factors -- Analysis ,Cell research -- Analysis ,Cytokines -- Analysis ,Biological sciences - Abstract
Inhibitory Smads (I-Smads) repress signaling by cytokines of the transforming growth factor-[beta] (TGF-[beta]) superfamily. I-Smads have conserved carboxy-terminal Mad homology 2 (MH2) domains, whereas the amino acid sequences of their amino-terminal regions (N domains) are highly divergent from those of other Smads. Of the two different I-Smads in mammals, Smad7 inhibited signaling by both TGF-[beta] and bone morphogenetic proteins (BMPs), whereas Smad6 was less effective in inhibiting TGF-[beta] signaling. Analyses using deletion mutants and chimeras of Smad6 and Smad7 revealed that the MH2 domains were responsible for the inhibition of both TGF-[beta] and BMP signaling by I-Smads, but the isolated MH2 domains of Smad6 and Smad7 were less potent than the full-length Smad7 in inhibiting TGF-[beta] signaling. The N domains of I-Smads determined the subcellular localization of these molecules. Chimeras containing the N domain of Smad7 interacted with the TGF-[beta] type I receptor (T[beta]R-I) more efficiently, and were more potent in repressing TGF-[beta] signaling, than those containing the N domain of Smad6. The isolated N domain of Smad7 physically interacted with the MH2 domain of Smad7, and enhanced the inhibitory activity of the latter through facilitating interaction with TGF-[beta] receptors. The N domain of Smad7 thus plays an important role in the specific inhibition of TGF-[beta] signaling.
- Published
- 2001